Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Normal thymocyte negative selection in TRAIL-deficient mice.

Erika Cretney1, Adam P Uldrich, Stuart P Berzins

  • 1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St., Melbourne, Victoria 8006, Australia.

The Journal of Experimental Medicine
|August 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conserved T cell receptor usage underpins recognition of CD1c presenting a mycobacterial lipid.

bioRxiv : the preprint server for biology·2026
Same author

A temporal map of B cell diversification mechanisms in mice.

Nature immunology·2026
Same author

Cell death in cancer.

Cell·2026
Same author

Specific targeting of MR1-antigen complexes using nanobodies.

bioRxiv : the preprint server for biology·2026
Same author

Sideways lipid presentation by the antigen-presenting molecule CD1c.

Nature communications·2025
Same author

Sideways lipid presentation by the antigen-presenting molecule CD1c.

bioRxiv : the preprint server for biology·2025

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling is not critical for thymocyte negative selection. Studies using TRAIL-deficient mice in multiple models confirmed TRAIL

Area of Science:

  • Immunology
  • Cellular and Molecular Immunology
  • T-cell development

Background:

  • Thymocyte negative selection is crucial for immunological tolerance but its molecular basis remains unclear.
  • The role of tumor necrosis factor (TNF)-family death receptors, including TNF-related apoptosis-inducing ligand (TRAIL), in this process is debated.
  • Previous studies yielded conflicting results regarding the involvement of TRAIL and its associated signaling pathway (FADD-caspase 8) in negative selection.

Purpose of the Study:

  • To investigate the role of TRAIL signaling in intrathymic negative selection of thymocytes.
  • To clarify the contribution of TRAIL to establishing and maintaining immunological tolerance.
  • To reconcile conflicting findings on TRAIL's involvement in T-cell development.

Main Methods:

Related Experiment Videos

  • Utilized TRAIL-deficient mice to assess thymocyte negative selection.
  • Employed four established models of negative selection: in vitro antibody-mediated TCR/CD3 ligation, in vitro and in vivo endogenous superantigen stimulation, and in vitro exogenous superantigen treatment.
  • Analyzed thymocyte populations and selection processes under these conditions.

Main Results:

  • No significant role for TRAIL signaling was observed in any of the tested models of thymocyte negative selection.
  • TRAIL-deficient thymocytes underwent normal negative selection in response to various stimuli.
  • These findings contradict recent reports suggesting a critical role for TRAIL.

Conclusions:

  • TRAIL signaling is not a critical factor in intrathymic thymocyte negative selection.
  • The FADD-caspase 8 pathway, essential for TRAIL, does not appear to be a major contributor to negative selection.
  • Further research is needed to fully elucidate the molecular mechanisms underlying thymocyte negative selection and immunological tolerance.